AdjuderaCommencer

Attribution

LOT 5: Pharmacoepidemiological research

Langue d’origine: anglais

Suivre cette ficheAvec Adjudera Pro, soyez alerté avant qu’un marché n’arrive à échéance.
Acheteur
European Medicines Agency, MED - European Medicines Agency
Titulaires
Agora Labs S.r.L., Biomedical Research Foundation, Academy of Athens – BRFAA, Certara France SARL, Critical Path Institute – Stichting, Danish medicines Agency, EPICONCEPT, ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM, Fundacion Publica Miguel Servet, Instituto Nacional de Saude Dr. Ricardo Jorge, IQVIA Solutions bv, MYO Health Policy Advisors P.C., OM1 bv, P95 bv, Panepistimio Patron, Quinten Health SAS, Universiteit Utrecht, University Medical Center Utrecht, Vaccine Monitoring Collaboration for Europe
Montant du marché
aucun montant publié
Offres reçues
14
Publié le
31 mars 2026
Attribution
17 mars 2026
Début d'exécution
17 mars 2026
Fin du marché
15 mars 2028estimée
Secteur
Recherche et développement
Région
Groot-Amsterdam
Source
Avis d'origine sur TED (224674-2026)

Autres attributions de cet acheteur

AttributionAcheteurTitulaireMontant du marchéPublié le
Data Management- Anonymization and redaction of documents and datasetsEuropean Medicines Agency, MED - European Medicines AgencyIQVIA Solutions Belgium B.V., Syneos Health Clinical Spain, S.L.U.—4 sept. 2026
LOT 7: Computational methods for comparison of molecular structural features in the context of medicines for rare diseasesEuropean Medicines Agency, MED - European Medicines AgencyIstituto di Ricerche Farmacologiche Mario Negri, KREATIS—1 sept. 2026
LOT 6: Innovative technologies for manufacturing and quality control of medicinesEuropean Medicines Agency, MED - European Medicines AgencyNATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED, RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH, UNIVERSITA DEGLI STUDI DI MILANO—1 sept. 2026
LOT 5: Pharmacoepidemiological researchEuropean Medicines Agency, MED - European Medicines AgencyAgora Labs S.r.L., Biomedical Research Foundation, Academy of Athens – BRFAA, Certara France SARL +15 autres—1 sept. 2026
LOT 4: Qualitative researchEuropean Medicines Agency, MED - European Medicines AgencyNHG Finland Oy, NIVEL, Oracle France S.A.S. +2 autres—1 sept. 2026
LOT 3: Methodological/statistical researchEuropean Medicines Agency, MED - European Medicines AgencyAgentschap College ter Beoordeling van Geneesmiddelen, Austrian Agency for Health and Food Safety GmbH, Danish medicines Agency +8 autres—1 sept. 2026